Edgewood Management
BIIB icon

Edgewood Management’s Biogen BIIB Stock Holding History

Edgewood Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,480
Closed -$463K – 88
2016
Q3 		$463K Buy
+1,480
New +$438K ﹤0.01% 64
2015
Q4 		– Sell
-2,000
Closed -$584K – 81
2015
Q3 		$584K Hold
2,000
– – ﹤0.01% 49
2015
Q2 		$808K Hold
2,000
– – 0.01% 45
2015
Q1 		$844K Buy
+2,000
New +$788K 0.01% 47

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Edgewood Management's BIIB Position: Q4 2016 in Review

Edgewood Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 1,480 shares — an estimated $463K sold.

Edgewood Management first reported a position in BIIB in Q1 2015 and held it in 4 quarters. The position peaked at $844K in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Edgewood Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Edgewood Management sold 1,480 Biogen shares in Q4 2016, an estimated $463K.
  • Edgewood Management first reported a position in Biogen in Q1 2015 and held it in 4 quarters.
  • Edgewood Management's Biogen position peaked at $844K in Q1 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Edgewood Management's 13F filing for Q4 2016, filed 10 Feb 2017.